Novel applications of ghrelin peptides in mouse models of inflammatory bowel disease

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/488811

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Inflammatory bowel disease (IBD) is a debilitating, chronic condition that often affects patients in the primes of their lives. A limited number of treatments are currently available for these patients and those that are available often have serious side effects, including growth restriction in children. Ghrelin is a natural hormone that has been shown to suppress many features of IBD. This project will investigate the potential of ghrelin as a new treatment for inflammatory bowel disease.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $243,116.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Sport and exercise nutrition

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Autoimmune disease | Colon Cancer | Ghrelin peptides as therapy | Immunomodulation of colitis | Inflammatory bowel disease | Intestinal inflammation and damage | Mouse models of colitis | Paediatric growth restriction in inflammatory bowel disease | Regeneration of intestinal epithelium

Related Links